Stay updated with breaking news from Brook Baker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After learning that a friend tested positive for COVID-19, Thembi Ndlovu went to a health clinic in Zimbabwe's capital in search of a free coronavirus test. But there were none left that day, leaving the 34-year-old hairdresser unsure if she needed to take precautions to protect clients.
HARARE, Zimbabwe -- After learning that a friend tested positive for COVID-19, Thembi Ndlovu went to a health clinic in Zimbabwe's capital in search of a fre...
HARARE, Zimbabwe (AP) — After learning that a friend tested positive for COVID-19, Thembi Ndlovu went to a health clinic in Zimbabwe's capital in search of a free coronavirus test. But there were none left that day, leaving the 34-year-old hairdresser unsure if she needed to take precautions to protect clients.
The sudden emergence of the Omicron variant of SARS-CoV-2 is adding pressure on vaccine makers to ensure their shots are available worldwide.
U.S. pharmaceutical giant Merck has agreed to share its license for its experimental covid-19 drug, molnupiravir, with a nonprofit organization so that it can be manufactured widely around the world in a deal that would expand access to the treatment in more than 100 countries.